Back
ESC2025 Premium Access

Elevated triglycerides are related to higher residual cardiovascular disease and mortality risk independent of lipid targets and lipid-lowering therapy intensity in cardiovascular disease patients

Session: Lipids (1)
Topic: Lipids
Speaker: Miss P. Schuitema (Utrecht, NL)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Miss Pauline Christine Eleonore Schuitema

University Medical Center Utrecht, Utrecht (Netherlands (The))
0 follower

7 more presentations in this session

The effect of baseline low-normal insulin-like growth factor-1 on the relation between lipoprotein (a) and incident type 2 diabetes and outcome: observations from the UK-Biobank.

Speaker: Doctor J. Sangha (Cambridge, GB)

Access
Abstract
Slides
Video
Like
Thumbnail

Project on lipid profile optimization in very high cardiovascular risk patients through a virtual lipid unit in our city healthcare area

Speaker: Doctor L. Villafafila (Toledo, ES)

Access
Abstract
Slides
Video
Like
Thumbnail

Validation of the familial hypercholesterolemia diagnosis in the Danish National Patient Registry and the Danish familial hypercholesterolemia registry

Speaker: Doctor J. Knold (Odense, DK)

Access
Abstract
Slides
Video
Like
Thumbnail

Elevated remnant cholesterol confers high risk of ASCVD without prompting lipid-lowering therapy: an unmet medical need

Speaker: Doctor K. Hvid (Herlev, DK)

Access
Abstract
Slides
Video
Like
Thumbnail

Discordance in the measurement of Achilles tendon thickness between soft X-ray radiography and ultrasonography among patients with coronary artery disease

Speaker: Doctor T. Itagaki (Matsumoto, JP)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Lipids (1)

Speakers: Miss P. Schuitema, Doctor J. Sangha, Doctor L. Villafafila, Doctor J. Knold, Doctor K. Hvid...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources